NuGen Medical Devices files corrective disclosure after OSC review of continuous disclosure

• NuGen Medical Devices filed corrective disclosure in its Aug. 17, 2026 management information circular following an Ontario Securities Commission review.
• The circular now includes missing executive compensation disclosure for the year ended Dec. 31, 2025, plus required governance disclosures.
• NuGen expects placement on the OSC public Refiling and Errors list for three years from the corrective refiling date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NuGen Medical Devices Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608271730NEWSFILECNPR____20260827_311906_1) on August 27, 2026, and is solely responsible for the information contained therein.